Intra-Cellular Therapies (ITCI) PT Raised to $107 at Canaccord Genuity
Tweet Send to a Friend
(Updated - April 23, 2024 6:44 AM EDT)
Canaccord Genuity analyst Sumant Kulkarni raised the price target on Intra-Cellular ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord Genuity analyst Sumant Kulkarni raised the price target on Intra-Cellular ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
